1. Home
  2. PRK vs TLX Comparison

PRK vs TLX Comparison

Compare PRK & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PRK

Park National Corporation

HOLD

Current Price

$172.04

Market Cap

3.1B

Sector

Finance

ML Signal

HOLD

Logo Telix Pharmaceuticals Limited American Depositary Shares

TLX

Telix Pharmaceuticals Limited American Depositary Shares

HOLD

Current Price

$9.52

Market Cap

3.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRK
TLX
Founded
1908
2015
Country
United States
Australia
Employees
N/A
1184
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
3.6B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
PRK
TLX
Price
$172.04
$9.52
Analyst Decision
Hold
Strong Buy
Analyst Count
3
4
Target Price
$184.00
$21.13
AVG Volume (30 Days)
63.3K
130.5K
Earning Date
04-24-2026
08-19-2026
Dividend Yield
2.61%
N/A
EPS Growth
19.21
N/A
EPS
2.39
N/A
Revenue
$664,421,000.00
N/A
Revenue This Year
$24.26
N/A
Revenue Next Year
$3.63
N/A
P/E Ratio
$72.37
$150.33
Revenue Growth
2.92
N/A
52 Week Low
$149.06
$6.28
52 Week High
$179.48
$17.25

Technical Indicators

Market Signals
Indicator
PRK
TLX
Relative Strength Index (RSI) 54.64 44.55
Support Level $169.82 $9.46
Resistance Level $176.73 $9.92
Average True Range (ATR) 3.25 0.24
MACD 0.16 -0.13
Stochastic Oscillator 91.92 39.71

Price Performance

Historical Comparison
PRK
TLX

About PRK Park National Corporation

Park National Corp is a diversified financial services company based in Newark, Ohio, consisting of 11 community banking divisions with more than 100 offices in Ohio and Kentucky. The company provides the following principal services: the acceptance of deposits for demand, savings and time accounts; commercial, industrial, consumer and real estate lending, including installment loans, credit cards (which are largely offered through a third party), home equity lines of credit and commercial leasing; trust and wealth management services; cash management; safe deposit operations; electronic funds transfers; and a variety of additional banking-related services.

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

Share on Social Networks: